| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.7M | -61.4% | +15.0% |
| R&D Expense | $5.8M | — | -49.1% |
| SG&A Expense | $17.7M | -31.5% | -3.5% |
| Operating Income | -$9.5M | -147.4% | +34.3% |
| Pre-tax Income | -$6.5M | — | +54.2% |
| Income Tax | -$1.5M | — | -175.0% |
| Net Income | -$4.9M | -108.1% | +63.7% |
| EPS (Basic) | -$0.10 | -108.3% | +63.0% |
| EPS (Diluted) | -$0.10 | -108.7% | +63.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $288.1M | +71.7% | +160.5% |
| Current Assets | $417.6M | -0.2% | +177.9% |
| Total Assets | $472.3M | -2.7% | +37.5% |
| Current Liabilities | $31.8M | -17.0% | +0.9% |
| Stockholders' Equity | $290.6M | -2.1% | +75.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $73.3M | — | +70.3% |
| Investing Cash Flow | $52.6M | — | +71.7% |
| Financing Cash Flow | -$5.6M | — | -553.0% |